A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia (AspECT)
This study is ongoing, but not recruiting participants.
Sponsor:
University of Oxford
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
University of Oxford
ClinicalTrials.gov Identifier:
NCT00357682
First received: July 26, 2006
Last updated: February 21, 2012
Last verified: February 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | March 2019 |
| Estimated Primary Completion Date: | March 2019 (Final data collection date for primary outcome measure) |